Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY294002 |
Trade Name | |
Synonyms | LY-294002|LY 294002|NSC-697286|SF-1101 |
Drug Descriptions |
LY294002 is a specific inhibitor of PI3K alpha, beta, and delta, which leads to inhibition of PI3K-Akt/PKB signaling (PMID: 12060641, PMID: 31759362, PMID: 31732769). |
DrugClasses | PI3K Inhibitor (Pan) 42 |
CAS Registry Number | 154447-36-6 |
NCIT ID | C148229 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cisplatin + LY294002 | Cisplatin LY294002 | 1 | 0 |
E6201 + LY294002 | E6201 LY294002 | 1 | 0 |
Gefitinib + LY294002 | Gefitinib LY294002 | 0 | 0 |
Imatinib + LY294002 | Imatinib LY294002 | 1 | 0 |
LY294002 | LY294002 | 1 | 0 |
LY294002 + RU-SKI 43 | LY294002 RU-SKI 43 | 0 | 0 |
LY294002 + Sirolimus | LY294002 Sirolimus | 0 | 0 |